Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

NOVO NORDISK A/S

(NOVO B)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur NOVO NORDISK A/S
03/12European ADRs Move Sharply Lower in Friday Trading
03/12Drugmakers cut prices by 62% on average to get China state insurance listing
29/11Novo Nordisk A/S – Share repurchase programme
26/11DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 26.11.2021 - 15.15 Uhr
26/11Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy
26/11MIDDAY BRIEFING - Unternehmen und Märkte -2-
26/11MASIH YAZDI : EUROPEAN MIDDAY BRIEFING - Stocks, Oil Drop on -2-
26/11AKTIEN EUROPA : Neue Coronavirus-Variante schlägt Anleger in die Flucht
26/11Novo Nordisk says lower insulin prices in China dent 2022 outlook
26/11Novo Nordisk Projects 3% Decline in 2022 Sales on Lower Insulin Sales in China
26/11NIEDRIGERE INSULINPREISE IN CHINA : Novo Nordisk rechnet mit Bremseffekt
26/11Novo Nordisk von niedrigeren Insulin-Preisen in China belastet
26/11Novo Nordisk Expects Lower Insulin Prices, Volumes in China to Dent FY22 Global Sales
26/11Novo Nordisk announces impact from Volume Based Procurement for insulin in China
25/11Novo Nordisk Announces Health Canada Approves Wegovy? for the Treatment of Adults with ..
18/11Health Care Stocks Ending Little Changed in Quiet Trading
18/11Health Care Stocks Weakening This Afternoon
18/11Dicerna Shares Soar on Takeover by Novo Nordisk
18/11Wall Street Set for Positive Open as Upbeat Nvidia Earnings Buoy Sentiment
18/11DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 18.11.2021 - 15.15 Uhr
18/11Health Care Stocks Edge Higher Premarket Thursday
18/11Novo Nordisk übernimmt Biotechnologie-Unternehmen Dicerna Pharmaceuticals
18/11Denmark's Novo Nordisk to buy Dicerna Pharma for $3.3 billion
18/11Novo Nordisk To Acquire Dicerna Pharmaceuticals
18/11Dicerna Pharmaceuticals Enters $3.3 Billion Deal to Be Acquired by Novo Nordisk
18/11Novo Nordisk to Buy Dicerna for $38.25 a Share
18/11Novo Nordisk kauft für 3,3 Mrd USD Partner Dicerna Pharmaceuticals
18/11FEATURE-CLIMATE-FRIENDLY FARMING : Greenland's melting glaciers offer an answer
18/11NOVO NORDISK A/S (CPSE : NOVO B) entered into a definitive merger agreement to acquire rem..
17/11PharmStars Announces Showcase Event for Inaugural Class
15/11Novo Nordisk A/S – Share repurchase programme
12/11BERICHT : 8,5 Millionen Typ-2-Diabetiker in Deutschland
12/11Investing in stability
12/11Novo Nordisk Receives European Medicines Agency's Nod For Label Extension On Diabetes D..
12/11Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the Eu..
12/11Novo Nordisk Announces Ozempic? 2.0 mg Recommended for Approval for the Treatment of Ty..
11/11Novo Nordisk's Obesity Treatment Wegovy Receives European Medicines Agency's Positive O..
11/11Novo Nordisk's Wegovy Gets Marketing Authorization Recommendation From European Medicin..
11/11Wegovy™ recommended for approval for the treatment of obesity by the European reg..
11/11District Courts Issue Key Decisions In 340B Contract Pharmacy Cases
08/11Novo Nordisk A/S – Share repurchase programme - Form 6-K
08/11Novo Nordisk A/S purchases B shares worth DKK 4,109 million from Novo Holdings A/S unde..
05/11Trading in Novo Nordisk shares by board members, executives and associated persons on 5..
05/11Novo Nordisk A/S purchases B shares worth DKK 4,109 million from Novo Holdings A/S unde..
05/11Novo Nordisk Says Trial Showed Significant Weight Loss With Wegovy Treatment Compared W..
05/11Novo Nordisk Says Wegovy Injections Led to Sustained Weight Loss in Two-Year Trial for ..
04/11Trading in Novo Nordisk shares by board members, executives and associated persons on 3..
04/11LAS OPINIONES DE LOS ANALISTAS DEL D : Merck, Pfizer, Hugo Boss, BMW, Zalando, Pfizer, Nes..
04/11Novo Nordisk Mulls Upgraded Sales Outlook for Obesity Drugs As Wegovy Takes Off
03/11Health Care Stocks Closing Near Intra-Day Highs
03/11Health Care Stocks Slipping This Afternoon
03/11AKTIEN EUROPA SCHLUSS : Freundlich vor US-Zinsentscheid - Cac mit Rekord
03/11GLOBAL MARKETS LIVE : Netflix, Pfizer, Amgen, CVS Health, T-Mobile US...
03/11MÄRKTE EUROPA/Ruhe nur in Indizes - Windkraft bricht ein
03/11MÄRKTE EUROPA/Ruhe täuscht - Kräftige Ausschläge bei Einzelaktien
03/11DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 03.11.2021 - 15.15 Uhr
03/11Health Care Stocks Mixed Premarket Wednesday
03/11MÄRKTE EUROPA/Turbulenz bei Einzelaktien - Windkraft unter Druck
03/11MarketScreener's World Press Review - November 3, 2021
03/11Novo Nordisk A/S Reports Earnings Results for the Third Quarter and Nine Months Ended S..
03/11After strong quarter, Novo Nordisk urges more competitive US obesity market
03/11Novo Nordisk Banks on Diabetes, Obesity Drugs to Reach Higher Full-Year Targets
03/11AKTIEN EUROPA : Zurückhaltung vor US-Zinsentscheid
03/11Novo Nordisk stockt Aktienrückkauf auf - Aktie auf Rekordhoch
03/11Novo Nordisk Posts Higher Q3 Results, Expands Share Repurchase Program
03/11MÄRKTE EUROPA/Lufthansa nach Zahlen sehr fest - Vestas-Kurs knickt ein
03/11NOVO NORDISK : Q3 Earnings Snapshot
03/11Es el día de la Fed
03/11Novo Nordisk übertrifft Erwartungen
03/11Novo Nordisk 3Q Earnings Beat Expectations, Boosted by New Obesity Drug
03/11Novo Nordisk Lifts FY21 Outlook As Q3 Profit Soars 18%
03/11Novo Nordisk's net profit increased by 12% in the first nine months of 2021
02/11Novo Nordisk A/S – Share repurchase programme - Form 6-K
02/11Novo Nordisk A/S – Share repurchase programme
29/10ADRs End Lower; Onion Global, Wolters Kluwer Among Companies Actively Trading
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur NOVO NORDISK A/S